Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 49, 2019 - Issue 10
222
Views
9
CrossRef citations to date
0
Altmetric
Xenobiotic transporters

Modulation of transporter activity of OATP1B1 and OATP1B3 by the major active components of Radix Ophiopogonis

, , , , , , & show all
Pages 1221-1228 | Received 15 May 2018, Accepted 24 Jun 2018, Published online: 11 Jun 2019

References

  • Chauvin B, Drouot S, Barrail-Tran A, et al. (2013). Drug-drug interactions between HMG-CoA reductase inhibitors (statins) and antiviral protease inhibitors. Clin Pharmacokinet 52:815–31.
  • Fenner KS, Jones HM, Ullah M, et al. (2012). The evolution of the OATP hepatic uptake transport protein family in DMPK sciences: from obscure liver transporters to key determinants of hepatobiliary clearance. Xenobiotica 42:28–45.
  • Giacomini KM, Shiew-Mei H, Tweedie DJ, et al. (2010). Membrane transporters in drug development. Nat Rev Drug Discov 9:215–36.
  • Gong IY, Kim RB. (2013). Impact of genetic variation in OATP transporters to drug disposition and response. Drug Metab Pharmacokinet 28:4–18.
  • Gui C, Hagenbuch B. (2009). Role of transmembrane domain 10 for the function of organic anion transporting polypeptide 1B1. Protein Sci 18:2298–306.
  • Hagenbuch B, Meier PJ. (2004). Organic anion transporting polypeptides of the OATP/SLC21 family: phylogenetic classification as OATP/SLCO superfamily, new nomenclature and molecular/functional properties. Pflugers Arch 447:653–65.
  • Jiang R, Dong J, Li X, et al. (2015). Molecular mechanisms governing different pharmacokinetics of ginsenosides and potential for ginsenoside-perpetrated herb-drug interactions on OATP1B3. Br J Pharmacol 172:1059–73.
  • Kalliokoski A, Niemi M. (2009). Impact of OATP transporters on pharmacokinetics. Br J Pharmacol 158:693–705.
  • Kindla J, Muller F, Mieth M, et al. (2011). Influence of non-steroidal anti-inflammatory drugs on organic anion transporting polypeptide (OATP) 1B1- and OATP1B3-mediated drug transport. Drug Metabol Dispos 39:1047–53.
  • Kock K, Xie Y, Hawke RL, et al. (2013). Interaction of silymarin flavonolignans with organic anion-transporting polypeptides. Drug Metabol Dispos 41:958–65.
  • König J. (2011). Uptake transporters of the human OATP family: molecular characteristics, substrates, their role in drug-drug interactions, and functional consequences of polymorphisms. Handbook Exp Pharmacol 1:28.
  • Koshland DE. (1958). Application of a Theory of Enzyme Specificity to Protein Synthesis. Proc Natl Acad Sci USA 44:98–104.
  • Lau YY, Okochi H, Huang Y, et al. (2006). Pharmacokinetics of atorvastatin and its hydroxy metabolites in rats and the effects of concomitant rifampicin single doses: relevance of first-pass effect from hepatic uptake transporters, and intestinal and hepatic metabolism. Drug Metabol Dispos 34:1175–81.
  • Maeda K. (2015). Organic anion transporting polypeptide (OATP)1B1 and OATP1B3 as important regulators of the pharmacokinetics of substrate drugs. Biol Pharm Bull 38:155–68.
  • Mandery K, Balk B, Bujok K, et al. (2012). Inhibition of hepatic uptake transporters by flavonoids. Eur J Pharm Sci 46:79–85.
  • Meier-Abt F, Mokrab Y, Mizuguchi K. (2006). Organic anion transporting polypeptides of the OATP/SLCO superfamily: identification of new members in nonmammalian species, comparative modeling and a potential transport mode. J Membr Biol 208:213–27.
  • Niemi M. (2007). Role of OATP transporters in the disposition of drugs. Pharmacogenomics 8:787–802.
  • Obaidat A, Roth M, Hagenbuch B. (2012). The expression and function of organic anion transporting polypeptides in normal tissues and in cancer. Annu Rev Pharmacol Toxicol 52:135–51.
  • Roth M, Timmermann BN, Hagenbuch B. (2011). Interactions of green tea catechins with organic anion-transporting polypeptides. Drug Metabol Dispos 39:920–6.
  • Singh N, Kumar S. (2015). TLC and HPLC fingerprint development of Aegle marmelos Corr. and its polyherbal marketed formulations. Int J Pharma Sci Res 6:162–7.
  • Tian YQ, Kou JP, Lin-Zhou LI, et al. (2011). Anti-inflammatory effects of aqueous extract from Radix Liriope muscari and its major active fraction and component. Chin J Nat Med 9:222–6.
  • Van de Steeg E, Greupink R, Schreurs M, et al. (2013). Drug-drug interactions between rosuvastatin and oral antidiabetic drugs occurring at the level of OATP1B1. Drug Metabol Dispos 41:592–601.
  • Xu F, Li Z, Zheng J, et al. (2013). The inhibitory effects of the bioactive components isolated from Scutellaria baicalensis on the cellular uptake mediated by the essential solute carrier transporters. J Pharm Sci 102:4205–11.
  • Zeng Y, Wang J, Zhou Y, et al. (2010). Effect of shenmai injection on mortality rate of patients with acute myocardial infarction: a systematic review. Mod J Integr Trad Chin Western Med 19:3555–8.
  • Zhang W, Xiong X, Chen L, et al. (2017). Hepatic uptake mechanism of ophiopogonin D mediated by organic anion transporting polypeptides. Eur J Drug Metab Pharmacokinet 42:669–76.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.